KANAMYCIN: 27 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
27
Total FAERS Reports
3 (11.1%)
Deaths Reported
7
Hospitalizations
27
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available
Active Ingredient: KANAMYCIN SULFATE · FDA Application: 060516 ·
First Report: 201209 · Latest Report: 20190311
What Are the Most Common KANAMYCIN Side Effects?
#1 Most Reported
Nausea
10 reports (37.0%)
#2 Most Reported
Anaemia
10 reports (37.0%)
#3 Most Reported
Vomiting
9 reports (33.3%)
All KANAMYCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 10 | 37.0% | 0 | 0 |
| Nausea | 10 | 37.0% | 0 | 1 |
| Vomiting | 9 | 33.3% | 1 | 1 |
| Neuropathy peripheral | 5 | 18.5% | 1 | 1 |
| Pancytopenia | 5 | 18.5% | 0 | 0 |
| Platelet count decreased | 5 | 18.5% | 0 | 0 |
| Pruritus | 5 | 18.5% | 0 | 0 |
| Restlessness | 5 | 18.5% | 0 | 0 |
Who Reports KANAMYCIN Side Effects? Age & Gender Data
Gender: 44.0% female, 56.0% male. Average age: 35.7 years. Most reports from: JP. View detailed demographics →
Is KANAMYCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 1 | 1 | 0 |
| 2016 | 2 | 1 | 2 |
| 2017 | 6 | 0 | 0 |
| 2018 | 6 | 0 | 0 |
| 2019 | 2 | 0 | 0 |
What Is KANAMYCIN Used For?
| Indication | Reports |
|---|---|
| Tuberculosis | 14 |
| Pulmonary tuberculosis | 8 |
Official FDA Label for KANAMYCIN
Official prescribing information from the FDA-approved drug label.